Capital Group Private Client Services, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1857666
Los Angeles, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,122,446
+$537,268 QoQ
Shares Held
18,365
-4.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#385
of 1,735 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Group Private Client Services, Inc. holds $15,735,459 across 2 Biotechnology names. VRTX ranks #1 (58.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
18,365 | $9,122,446 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
23,206 | $6,613,013 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,122,446 | 18,365 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $8,585,178 | 19,226 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,813,542 | 23,852 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $9,741,653 | 24,874 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $46,539,872 | 104,537 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $12,426,906 | 25,632 | Shares | Defined | 2025-05-12 | |
| 2022-03-31 | $14,934,269 | 57,226 | Shares | Sole | 2022-05-19 | |
| 2021-12-31 | $12,553,653 | 57,166 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,271,030 | 62,137 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||